Characterization of deaths from malignant neoplasms of the esophagus, a portrait of Brazil from the last 10 years (2015-2024).

Authors

  • Lucas Ramon Barbosa Matos FACULDADE PITÁGORAS – Campus Eunápolis/ Bahia
  • Matheus Brito Zavarize Faculdade Pitágoras - Campus Eunápolis
  • Louyse Morgana Rodrigues Miranda Faculdade Pitágoras - Campus Eunápolis
  • Erick Costa Aguiar Faculdade Pitágoras - Campus Eunápolis
  • Henika Priscila Lima Silva Faculdade Pitágoras - Campus Eunápolis
  • Kenzo Brito de Souza Faculdade Pitágoras - Campus Eunápolis

DOI:

https://doi.org/10.36557/2674-8169.2025v7n5p1787-1796

Keywords:

Neoplasias Esofágicas, Registros de Mortalidade, Epidemiologia

Abstract

INTRODUCTION: Esophageal cancer is an aggressive neoplasm with high mortality rates, the patterns of which vary according to the histological subtype in each region. Early detection and prevention are essential to improve survival. METHODOLOGY: This observational, cross-sectional, and retrospective study analyzed the profile of hospital deaths due to Malignant Esophageal Neoplasm in Brazil (2015-2024) based on data available in SIM/DATASUS, using the variables year, region, sex, age, and race/color. The collected data were tabulated in an Excel spreadsheet and analyzed descriptively. CONCLUSION: Mortality remains high, with significant regional variations, reinforcing the need for prevention, early diagnosis, and access to therapeutic treatments. Public policies should reduce socioeconomic disparities and improve epidemiological records.

Downloads

Download data is not yet available.

References

ABNET, C. C.; ARNOLD, M.; WEI, W. Q. Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology, v. 154, n. 2, p. 360–373, jan. 2018. DOI: 10.1053/j.gastro.2017.08.023. Erratum in: Gastroenterology. 2018 Oct;155(4):1281. Disponível em: http://doi.org/10.1053/j.gastro.2018.09.048.

ARNOLD, M. et al. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. American Journal of Gastroenterology, v. 112, n. 8, p. 1247–1255, ago. 2017. DOI: 10.1038/ajg.2017.155.

BRAY, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, v. 68, n. 6, p. 394–424, nov. 2018. DOI: 10.3322/caac.21492. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. Disponível em: http://doi.org/10.3322/caac.21609.

ENOMOTO, N. et al. Current status of immune checkpoint inhibitor therapy for advanced esophageal squamous cell carcinoma. Global Health & Medicine, v. 3, n. 6, p. 378–385, 31 dez. 2021. DOI: 10.35772/ghm.2020.01112.

FERLAY, J. et al. Cancer statistics for the year 2020: An overview. International Journal of Cancer, 5 abr. 2021. DOI: 10.1002/ijc.33588.

HIROSE, T.; YAMAMOTO, S.; KATO, K. Pembrolizumab for first-line treatment of advanced unresectable or metastatic esophageal or gastroesophageal junction cancer. Therapeutic Advances in Gastroenterology, v. 16, 10 jan. 2023. DOI: 10.1177/17562848221148250.

INSTITUTO NACIONAL DE CÂNCER (INCA). Câncer de esôfago. 2020. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/tipos/esofago#:~:text=No%20Brasil%2C%20o%20c%C3%A2ncer%20de,com%20o%20Servi%C3%A7o%20de%20Sa%C3%BAde.

INSTITUTO NACIONAL DE CÂNCER (INCA). Câncer de esôfago. 2020. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/tipos/esofago.

INSTITUTO NACIONAL DE CÂNCER (INCA). Estimativa 2023: Incidência de câncer no Brasil. Rio de Janeiro: INCA, 2023. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2023.pdf.

INSTITUTO NACIONAL DE CÂNCER (INCA). Pesquisa do INCA mostra que consumo de álcool deixa marcas genéticas que podem causar câncer de esôfago. 2021. Disponível em: https://www.gov.br/inca/pt-br/assuntos/noticias/2021/pesquisa-do-inca-mostra-que-consumo-de-alcool-deixa-marcas-geneticas-que-podem-causar-cancer-de-esofago.

LAGERGREN, J.; LAGERGREN, P. Oesophageal cancer. BMJ, v. 341, c6280, 26 nov. 2010. DOI: 10.1136/bmj.c6280.

LAGERGREN, J.; SMYTH, E.; CUNNINGHAM, D.; LAGERGREN, P. Oesophageal cancer. The Lancet, v. 390, n. 10110, p. 2383–2396, 2017. DOI: 10.1016/S0140-6736(17)31462-9.

NING, X. Y. et al. Role of exosomes in metastasis and therapeutic resistance in esophageal cancer. World Journal of Gastroenterology, v. 29, n. 42, p. 5699–5715, 14 nov. 2023. DOI: 10.3748/wjg.v29.i42.5699.

SIEGEL, R. L. et al. Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, v. 71, n. 1, p. 7–33, jan. 2021. DOI: 10.3322/caac.21654.

SUNG, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, v. 71, n. 3, p. 209–249, maio 2021. DOI: 10.3322/caac.21660.

VAN HAGEN, P. et al. Preoperative chemoradiotherapy and surgery versus surgery alone for resectable esophageal cancer. New England Journal of Medicine, v. 366, n. 22, p. 2074–2084, 2012. DOI: 10.1056/NEJMoa1112088. Disponível em: https://www.nejm.org/doi/full/10.1056/NEJMoa1112088.

WORLD HEALTH ORGANIZATION. Global Cancer Observatory: Cancer Survival. Lyon: IARC, 2022.

Downloads

Published

2025-05-31

How to Cite

Barbosa Matos, L. R., Brito Zavarize, M., Morgana Rodrigues Miranda, L., Costa Aguiar, E., Priscila Lima Silva, H., & Brito de Souza, K. (2025). Characterization of deaths from malignant neoplasms of the esophagus, a portrait of Brazil from the last 10 years (2015-2024). Brazilian Journal of Implantology and Health Sciences, 7(5), 1787–1796. https://doi.org/10.36557/2674-8169.2025v7n5p1787-1796

Issue

Vol. 7 No. 5 (2025): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807 - ÍNDICE H 22

Section

Original article

License

Copyright (c) 2025 Lucas Ramon Barbosa Matos, Matheus Brito Zavarize, Louyse Morgana Rodrigues Miranda, Erick Costa Aguiar, Henika Priscila Lima Silva, Kenzo Brito de Souza

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors are copyright holders under a CCBY 4.0 license.